Distinct immunophenotypic and clinical features of TP53-mutated acute myeloid leukemia: high CD34/CD41 expression and lower leukocyte counts.
Saved in:
| Title: | Distinct immunophenotypic and clinical features of TP53-mutated acute myeloid leukemia: high CD34/CD41 expression and lower leukocyte counts. |
|---|---|
| Authors: | Park S; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul Metropolitan Government Seoul National University (SMG-SNU) Boramae Medical Center, Seoul, 07061, Republic of Korea., Kim SA; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, 13620, Gyeonggi-do, Republic of Korea., Kim S; Center for Precision Medicine, Seoul National University Hospital, Seoul, 03080, Republic of Korea.; Center for Medical Innovation, Clinical Research Institute, Seoul National University Hospital, Seoul, 03080, Republic of Korea., Kim SY; Department of Laboratory Medicine, Seoul National University Hospital, Seoul, 03080, Republic of Korea., Lee JY; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, 13620, Gyeonggi-do, Republic of Korea., Byun JM; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, 03080, Republic of Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea., Hwang SM; Department of Laboratory Medicine, Seoul National University Bundang Hospital, Seongnam-si, 13620, Gyeonggi-do, Republic of Korea., Lee JO; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, 13620, Gyeonggi-do, Republic of Korea., Koh Y; Center for Medical Innovation, Clinical Research Institute, Seoul National University Hospital, Seoul, 03080, Republic of Korea.; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, 03080, Republic of Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea., Hong J; Center for Medical Innovation, Clinical Research Institute, Seoul National University Hospital, Seoul, 03080, Republic of Korea.; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, 03080, Republic of Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea., Chang YH; Department of Laboratory Medicine, Seoul National University Hospital, Seoul, 03080, Republic of Korea., Kim HK; Department of Laboratory Medicine, Seoul National University Hospital, Seoul, 03080, Republic of Korea., Bang SM; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, 13620, Gyeonggi-do, Republic of Korea., Kim I; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, 03080, Republic of Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea., Yoon SS; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, 03080, Republic of Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea., Shin DY; Center for Medical Innovation, Clinical Research Institute, Seoul National University Hospital, Seoul, 03080, Republic of Korea. shindongyeop@snu.ac.kr.; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, 03080, Republic of Korea. shindongyeop@snu.ac.kr.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea. shindongyeop@snu.ac.kr. |
| Source: | Annals of hematology [Ann Hematol] 2026 Apr 21; Vol. 105 (5). Date of Electronic Publication: 2026 Apr 21. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-0584 |
|---|---|
| DOI: | 10.1007/s00277-026-07001-4 |
